The U.S. Food and Drug Administration and the European Medicines Agency jointly issued principles for safe and responsible ...
Nvidia and Eli Lilly are teaming up on a $1 billion AI-powered lab to accelerate drug discovery, combining robotics, ...
AI and machine learning are revolutionizing drug discovery, development, and lifecycle management, addressing industry ...
Stocktwits on MSN
Pfizer CEO eyes big push towards obesity drug development in 2026 after $10B Metsera acquisition
Pfizer scrapped its own obesity drug candidate, Danuglipron, in early 2025, citing risks of liver enzyme elevations. ・The ...
The San Diego firm took a step in that direction on Tuesday, when it unveiled what it says will be the world’s largest ...
SAN FRANCISCO, Jan 13 () - AstraZeneca has agreed to buy Boston-based Modella AI, the companies said on Tuesday, as the drug ...
Accelerated drug discovery and development platform Converge Bio Inc. today announced it has raised $25 million in ...
Orphan Drug Designation applies to approximately 50,000 Patients who predominantly suffer from severe chronic pain due to ...
Persist AI is a drug formulation technology company that developed artificial intelligence-powered Cloud Lab, a remote, cloud ...
Looking to overcome some of the limitations of existing obesity drugs, Alveus Therapeutics has debuted with nearly $160 ...
In Darwinian terms, survival isn’t a matter of being the biggest, the fastest, or the strongest of the species, but instead ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback